
GTS-21 - Wikipedia
GTS-21 (DMXBA or DMBX-anabaseine) is a drug has been ability to potentially enhance memory and cognitive function. It has been studied for its potential therapeutic uses, particularly in the treatment of neurodegenerative diseases and psychiatric disorders.
GTS-21: Uses, Interactions, Mechanism of Action - DrugBank Online
Nov 18, 2007 · GTS-21 (also known as DMBX-A), is a novel, small-molecule, orally active and selective alpha-7 nicotinic acetylcholine (nACh) receptor agonist that has demonstrated memory and cognition enhancement activity in human clinical trials.
The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS …
A synthetic derivative, 3- (2,4-Dimethoxybenzylidene)-Anabaseine (DMXBA; also called GTS-21), improves memory in experimental animals and humans and is currently in clinical trials to determine whether it can ameliorate cognitive problems associated with schizophrenia.
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for ...
DMXB-A improved performance on both the repeatable battery for assessment for neuropsychological status (RBANS) total scale score and the attention scale. DMXB-A also normalized the P50 ratio as well as the test wave amplitude, a more specific measure of inhibition.
DMXB-A: Uses, Dosage, Side Effects, Food Interaction & FAQ
Jan 7, 2025 · DMXB-A (also known as DMBX-A), is a novel, small-molecule, orally active and selective alpha-7 nicotinic acetylcholine (nACh) receptor agonist that has demonstrated memory and cognition enhancement activity in human clinical trials.
Dmxb-A | C19H20N2O2 | CID 5310985 - PubChem
GTS-21 (also known as DMBX-A), is a novel, small-molecule, orally active and selective alpha-7 nicotinic acetylcholine (nACh) receptor agonist that has demonstrated memory and cognition enhancement activity in human clinical trials.
Initial phase 2 trial of a nicotinic agonist in schizophrenia
The agent 3- (2,4-dimethoxybenzylidene) anabaseine (DMXB-A) is a partial alpha (7)-nicotinic agonist and can be taken orally. A phase 1 trial showed evidence for cognitive enhancement in schizophrenia.
DMXB (GTS-21) ameliorates the cognitive deficits in beta
We found that the treatment with DMXB on days 1-10 after Abeta (25-35) injection dose-dependently prevented Abeta (25-35)-induced impairment of acquisition performance and probe trail test in Morris water maze.
GTS-21 dihydrochloride (DMXB-A) | α7-nAChR Agonist
GTS-21 dihydrochloride is a selective alpha7 nicotinic acetylcholine receptor (α7-nAChR) agonist with anti‑inflammatory and cognition‑enhancing activities. GTS-21 dihydrochloride is also a α4β2 (K i. =20 nM for humanα4β2) and 5-HT3A receptor (IC50 =3.1 μM) antagonist [1] [2].
alpha7 receptor-selective agonists and modes of alpha7 receptor ...
Mar 30, 2000 · The alpha7-selective agonists 3-(2, 4-dimethoxybenzylidene)-anabaseine (GTS-21), also known as DMXB, and 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) produce a variety of behavioral and cytoprotective effects that may be related to the activation of either large transient currents at hi …
- Some results have been removed